BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Abbott Diabetes Care Issues Nationwide Urgent Medical Device Correction For Blood Glucose Meters


10/19/2005 5:13:22 PM

ALAMEDA, Calif., Oct. 14 /PRNewswire-FirstCall/ -- Abbott Diabetes Care, a division of Abbott located in Alameda, Calif., is voluntarily initiating a correction and notification to users of its blood glucose meters in the United States. The products are sold under several model names in the United States including FreeStyle(R), FreeStyle Flash(TM), FreeStyle Tracker(TM), Precision Xtra(TM), MediSense(R) Sof-Tact(TM), and MediSense(R) Optium(TM). Private label brands include ReliOn(R) Ultima, Rite Aid(R) and Kroger(R) blood glucose meters. Test strips are not affected by this correction.

Abbott Diabetes Care's blood glucose meters are designed to allow patients to display one of two standard units of measure; either milligrams per deciliter (mg/dL), the U.S. standard; or millimoles per liter (mmol/L), a standard commonly used in other countries. The company has received consumer complaints that in the course of setting the time and date for their meters, users have inadvertently changed the units of measure from milligrams per deciliter (mg/dL) to millimoles per liter (mmol/L). This could lead to misinterpretation of test results with possible under-treatment and the potential for hyperglycemia. Abbott Diabetes Care has filed 17 medical device reports in the United States associated with this issue based on a U.S. user base of 2.25 million.

Consumers using Abbott Diabetes Care blood glucose meters may continue to safely use their meters and should verify that their meter is displaying the correct unit of measure each time they test. Consumers with questions may call Abbott Diabetes Care customer care at 1-800-553-4105.

Abbott Diabetes Care's blood glucose meters in the United States are distributed primarily through retail and mail order pharmacies, and physician offices. In order to ensure Abbott Diabetes Care customers only receive results in their country's standard, the company is taking several steps to eliminate any confusion, including: locking the meter's unit of measure with the standard of the country to which it is being shipped, revising meter manuals, and posting information to its web site, http://AbbottDiabetesCare.com .

Abbott is working with the U.S. Food and Drug Administration (FDA) to execute this voluntary medical device correction.

Abbott

CONTACT: Media, Tama Antonia Donaldson, +1-510-749-5449, or Melissa Brotz,+1-847-935-3456, or Financial Community, John Thomas, +1-847-938-2655, allfor Abbott



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES